Harpagoside ameliorates the amyloid-β-induced cognitive impairment in rats via up-regulating BDNF expression and MAPK/PI3K pathways
| Autor: | Weixiong Jiang, Erxi Wu, Junmin Li, R. Zhang, Yongfang Zhang, Zongqin Xia, X. Wang, Xuebing Ding, Xuejun Sun, Yaer Hu |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
MAPK/ERK pathway
Male Neurite MAP Kinase Signaling System Spatial Learning Pharmacology Neuroprotection Hippocampus Rats Sprague-Dawley Cognition Neurotrophic factors Alzheimer Disease medicine Animals Glycosides Pyrans Cerebral Cortex Neurons Amyloid beta-Peptides Chemistry General Neuroscience Brain-Derived Neurotrophic Factor Neurodegeneration Neurotoxicity Recognition Psychology medicine.disease Choline acetyltransferase Cholinergic Neurons Peptide Fragments Rats Up-Regulation Neuroprotective Agents Trk receptor Neuroscience |
| Zdroj: | Neuroscience. 303 |
| ISSN: | 1873-7544 |
| Popis: | So far, no effective disease-modifying therapies for Alzheimer's disease (AD) aiming at protecting or reversing neurodegeneration of the disease have been established yet. The present work aims to elucidate the effect of Harpagoside (abbreviated HAR), an iridoid glycosides purified from the Chinese medicinal herb Scrophularia ningpoensis, on neurodegeneration induced by β-amyloid peptide (Aβ) and the underlying molecular mechanism. Here we show that HAR exerts neuroprotective effects against Aβ neurotoxicity. Rats injected aggregated Aβ₁₋₄₀ into the bilateral hippocampus displayed impaired spatial learning and memory ability in a Y-maze test and novel object recognition test, while HAR treatment ameliorated Aβ₁₋₄₀-induced behavioral deficits. Moreover, administration of HAR increased the expression levels of brain-derived neurotrophic factor (BDNF) and activated the extracellular-regulated protein kinase (ERK) and the phosphatidylinositol 3-kinase (PI3-kinase) pathways both in the cerebral cortex and hippocampus of the Aβ₁₋₄₀-insulted rat model. Furthermore, in cultured primary cortical neurons, Aβ₁₋₄₂ induced significant decrease of choline acetyltransferase (ChAT)-positive neuron number and neurite outgrowth length, both of which were dose dependently increased by HAR. In addition, HAR pretreatment also significantly attenuated the decrease of cell viability in Aβ₁₋₄₂-injured primary cortical neurons. Finally, when K252a, an inhibitor of Trk tyrosine kinases, and a BDNF neutralizing antibody were added to the culture medium 2 h prior to HAR addition, the protective effect of HAR on Aβ₁₋₄₂-induced neurodegeneration in the primary cortical neuron was almost inhibited. Taken together, HAR exerting neuroprotection effect and ameliorating learning and memory deficit appears to be associated, at least in part, with up-regulation of BDNF content as well as activating its downstream signaling pathways, e.g., MAPK/PI3K pathways. It raises the possibility that HAR has potential to be a therapeutic agent against AD. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect